Understanding the Economic Toll of Rare Disease in the United States

Annie Kennedy, chief of policy and advocacy at the EveryLife Foundation for Rare Diseases, discusses the organization’s new study that finds nearly a $1 trillion economic burden of rare disease in the United States in 2019, the policy implications, and why the numbers are conservative.